Individual and Community Factors Associated With Geographic Clusters of Poor HIV Care Retention and Poor Viral Suppression

Eberhart, Michael G.; Yehia, Baligh R.; Hillier, Amy; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 69:S37-S43, May 1, 2015.

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

Metzger, David S.; Donnell, Deborah; Celentano, David D.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 68(5):554-561, April 15, 2015.

Innate Activation of MDC and NK Cells in High-Risk HIV-1–Exposed Seronegative IV-Drug Users Who Share Needles When Compared With Low-Risk Nonsharing IV-Drug User Controls

Tomescu, Costin; Seaton, Kelly E.; Smith, Peter; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 68(3):264-273, March 1, 2015.

Not Just the Needle: The State of HIV-Prevention Science Among Substance Users and Future Directions

Shoptaw, Steve; Montgomery, Brooke; Williams, Chyvette T.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63:S174-S178, July 1, 2013.

Randomized, Controlled Evaluation of a Prototype Informed Consent Process for HIV Vaccine Efficacy Trials

Coletti, Anne S.; Heagerty, Patrick; Sheon, Amy R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 32(2):161-169, February 1, 2003.

Randomized, Controlled Evaluation of a Prototype Informed Consent Process for HIV Vaccine Efficacy Trials.

Coletti, Anne S.; Heagerty, Patrick; Sheon, Amy R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 32(2):161-169, February 2003.

Human Immunodeficiency Virus Seroconversion Among Intravenous Drug Users In- and Out-of-Treatment: An 18-Month Prospective Follow-Up.

Metzger, David S.; Woody, George E.; McLellan, A. Thomas; More

Journal of Acquired Immune Deficiency Syndromes . 6(9):1049-1056, September 1993.